Will Angola

Naples FL – April 8, 2025 The NCH Rooney Heart Institute has successfully performed its first thoracic branch endoprosthesis procedure, marking another major advancement in cardiac and vascular care at Naples Comprehensive Health (NCH). The procedure was performed by Alvaro Zamora, MD and Santiago Chahwan, MD, leading vascular specialists at NCH, using the innovative FDA

NCH is proud to recognize Dr. Robert Cubeddu, Brynne and Bob Coletti Endowed Chair for the President of the Rooney Heart Institute, and Dr. Dee Dee Wang, Section Head of Cardiac Imaging, for their recent feature in Cardiovascular Business. In the article, they share insights on how the NCH Rooney Institute is transforming cardiovascular care-

NAPLES, FL, March 31, 2025 – Naples Comprehensive Health (NCH) proudly announces a $10 million gift from Jay and Patty Baker toward the RM Schulze Family Heart and Stroke Critical Care Center, a $265 million facility on the NCH Downtown Baker Hospital campus that will transform cardiac, stroke and vascular care in Southwest Florida. Funded

Naples FL – March 31, 2025 – The NCH Rooney Heart Institute has successfully completed a clinical trial of the Affera™ Mapping and Ablation System featuring the Sphere-9™ Catheter, a next-generation technology designed to enhance the treatment of atrial fibrillation (AF) and other complex cardiac arrhythmias. NCH is one of only two sites in the

NCH’s new orthopedic facility at the North Campus in Naples, developed in partnership with the Hospital for Special Surgery (HSS), is nearing completion and set to open in May 2025. The 80,000-square-foot, $120 million facility will offer comprehensive orthopedic care, including a surgery center, rehabilitation center, and 15 private overnight rooms. HSS, ranked No. 1

Naples, FL – March 5, 2025, NCH is proud to announce the opening of its newly relocated Outpatient Infusion Center now serving patients at 681 4th Ave. This expansion is made possible by a generous foundational gift from philanthropists Jim and Fran McGlothlin, whose support ensures that cancer patients and others requiring infusion therapy can